These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27701680)

  • 1. [Urolithiasis in the Long-Term GnRH Agonist Treatment of Patients with Paraphilia: 3 Case Studies].
    Mayrhofer G; Wegner D; Voß T
    Aktuelle Urol; 2016 Dec; 47(6):487-490. PubMed ID: 27701680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged flare-up of testosterone after administration of a gonadotrophin agonist to a sex offender: an under-recognised risk?
    Huygh J; Verhaegen A; Goethals K; Cosyns P; De Block C; Van Gaal L
    Crim Behav Ment Health; 2015 Jul; 25(3):226-30. PubMed ID: 25851640
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review.
    Briken P; Hill A; Berner W
    J Clin Psychiatry; 2003 Aug; 64(8):890-7. PubMed ID: 12927003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic treatment of paraphilias.
    Assumpção AA; Garcia FD; Garcia HD; Bradford JM; Thibaut F
    Psychiatr Clin North Am; 2014 Jun; 37(2):173-81. PubMed ID: 24877704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Side effects of treatment with the long-acting gonadorelin agonist triptorelin in a case of paraphilia].
    Hoogeveen JH; van der Veer E
    Tijdschr Psychiatr; 2007; 49(2):111-5. PubMed ID: 17290340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription of testosterone-lowering medications for sex offender treatment in German forensic-psychiatric institutions.
    Turner D; Basdekis-Jozsa R; Briken P
    J Sex Med; 2013 Feb; 10(2):570-8. PubMed ID: 23088739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side effects of pharmacotherapy on bone with long-acting gonadorelin agonist triptorelin for paraphilia.
    Hoogeveen J; Van der Veer E
    J Sex Med; 2008 Mar; 5(3):626-30. PubMed ID: 17971105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia.
    Thibaut F; Cordier B; Kuhn JM
    Acta Psychiatr Scand; 1993 Jun; 87(6):445-50. PubMed ID: 8356897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate].
    Briken P; Berner W; Noldus J; Nika E; Michl U
    Nervenarzt; 2000 May; 71(5):380-5. PubMed ID: 10846713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of men with paraphilia.
    Bradford JM
    N Engl J Med; 1998 Feb; 338(7):464-5. PubMed ID: 9459652
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hormonal pharmacotherapy: balancing between politics and evidence-based medicine].
    van Panhuis PJ
    Tijdschr Psychiatr; 2007; 49(2):117-8. PubMed ID: 17290341
    [No Abstract]   [Full Text] [Related]  

  • 12. Depot-leuprolide acetate for treatment of paraphilias: a report of twelve cases.
    Krueger RB; Kaplan MS
    Arch Sex Behav; 2001 Aug; 30(4):409-22. PubMed ID: 11446201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Paraphilia with Osteoporosis and Administered with Depot Leuprorelin.
    Kim D; Kim KM; Lim MH
    Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31635190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics.
    Czerny JP; Briken P; Berner W
    Eur Psychiatry; 2002 Apr; 17(2):104-6. PubMed ID: 11973119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocols for the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia.
    Reilly DR; Delva NJ; Hudson RW
    Can J Psychiatry; 2000 Aug; 45(6):559-63. PubMed ID: 10986575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists.
    Briken P; Nika E; Berner W
    J Sex Marital Ther; 2001; 27(1):45-55. PubMed ID: 11224953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotrophin hormone releasing hormone agonist in cases of severe paraphilia: a lifetime treatment?
    Thibaut F; Cordier B; Kuhn JM
    Psychoneuroendocrinology; 1996 May; 21(4):411-9. PubMed ID: 8844879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review.
    Turner D; Briken P
    J Sex Med; 2018 Jan; 15(1):77-93. PubMed ID: 29289377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone treatment of sex offenses].
    Thibaut F; Kuhn JM; Cordier B; Petit M
    Encephale; 1998; 24(2):132-7. PubMed ID: 9622792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.